$7.67 Billion is the total value of Baupost Group's 44 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 59.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LNG | Sell | CHENIERE ENERGY INC | $900,122,000 | -25.9% | 21,726,340 | -22.0% | 11.74% | -32.0% |
| VSAT | Buy | VIASAT INC | $871,332,000 | +1.2% | 13,158,137 | +14.1% | 11.36% | -7.2% |
| SYF | Buy | SYNCHRONY FINL | $749,520,000 | +52.4% | 20,665,000 | +17.6% | 9.77% | +39.8% |
| AGN | Buy | ALLERGAN PLC | $720,881,000 | +56.3% | 3,432,603 | +71.5% | 9.40% | +43.4% |
| FOXA | Buy | TWENTY FIRST CENTY FOX INCcl a | $536,615,000 | +73.8% | 19,137,469 | +50.1% | 7.00% | +59.4% |
| PBF | PBF ENERGY INCcl a | $438,390,000 | +23.1% | 15,724,175 | 0.0% | 5.72% | +13.0% | |
| DVMT | DELL TECHNOLOGIES INC | $365,686,000 | +15.0% | 6,652,459 | 0.0% | 4.77% | +5.5% | |
| AR | ANTERO RES CORP | $343,064,000 | -12.2% | 14,505,881 | 0.0% | 4.47% | -19.5% | |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $295,655,000 | +11.0% | 9,273,991 | +26.2% | 3.86% | +1.8% |
| NSAM | Buy | NORTHSTAR ASSET MGMT GROUP I | $279,079,000 | +117.7% | 18,705,000 | +88.7% | 3.64% | +99.7% |
| NRF | Buy | NORTHSTAR RLTY FIN CORP | $220,844,000 | +205.0% | 14,577,134 | +165.1% | 2.88% | +179.8% |
| FOX | TWENTY FIRST CENTY FOX INCcl b | $198,328,000 | +10.1% | 7,278,100 | 0.0% | 2.59% | +1.1% | |
| VRTV | VERITIV CORP | $163,636,000 | +7.1% | 3,044,385 | 0.0% | 2.13% | -1.8% | |
| INVA | INNOVIVA INC | $159,767,000 | -2.6% | 14,931,483 | 0.0% | 2.08% | -10.7% | |
| KERX | KERYX BIOPHARMACEUTICALS INC | $151,139,000 | +10.4% | 25,791,678 | 0.0% | 1.97% | +1.3% | |
| CLNY | Buy | COLONY CAP INCcl a | $140,920,000 | +73.9% | 6,959,017 | +56.5% | 1.84% | +59.5% |
| MCK | New | MCKESSON CORP | $140,450,000 | – | 1,000,000 | +100.0% | 1.83% | – |
| FWP | FORWARD PHARMA A/Ssponsored adr | $80,510,000 | -28.5% | 5,367,300 | 0.0% | 1.05% | -34.4% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $76,107,000 | -33.6% | 5,359,632 | 0.0% | 0.99% | -39.1% | |
| CAH | New | CARDINAL HEALTH INC | $74,129,000 | – | 1,030,000 | +100.0% | 0.97% | – |
| BATRK | LIBERTY MEDIA CORP DELAWARE | $61,647,000 | +18.5% | 2,994,010 | 0.0% | 0.80% | +8.6% | |
| AIGWS | AMERICAN INTL GROUP INC*w exp 01/19/202 | $60,863,000 | +10.7% | 2,594,317 | 0.0% | 0.79% | +1.5% | |
| SYT | New | SYNGENTA AGsponsored adr | $58,903,000 | – | 745,136 | +100.0% | 0.77% | – |
| LVNTA | New | LIBERTY INTERACTIVE CORP | $54,631,000 | – | 1,481,719 | +100.0% | 0.71% | – |
| CACC | Buy | CREDIT ACCEP CORP MICH | $53,159,000 | +164.4% | 244,400 | +144.4% | 0.69% | +142.3% |
| IMOS | New | CHIPMOS TECHNOLOGIES INCsponsored adr | $49,524,000 | – | 3,509,858 | +100.0% | 0.65% | – |
| GTYHU | New | GTY TECHNOLOGY HOLDINGS INCunit 99/99/9999 | $46,200,000 | – | 4,400,000 | +100.0% | 0.60% | – |
| CDEV | New | CENTENNIAL RESOURCE DEV INCcl a | $43,567,000 | – | 2,407,153 | +100.0% | 0.57% | – |
| NG | NOVAGOLD RES INC | $43,320,000 | -18.6% | 9,500,000 | 0.0% | 0.56% | -25.3% | |
| ABC | New | AMERISOURCEBERGEN CORP | $39,288,000 | – | 502,474 | +100.0% | 0.51% | – |
| Sell | THERAVANCE INCnote 2.125% 1/1 | $38,371,000 | -5.4% | 46,230,000 | -4.1% | 0.50% | -13.2% | |
| CPAA | CONYERS PK ACQUISITION | $37,979,000 | +2.3% | 3,712,500 | 0.0% | 0.50% | -6.2% | |
| New | THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $34,059,000 | – | 30,000,000 | +100.0% | 0.44% | – | |
| PRTK | PARATEK PHARMACEUTICALS INC | $31,485,000 | +18.4% | 2,044,498 | 0.0% | 0.41% | +8.5% | |
| SCAC | New | SABAN CAP ACQUISITION CORP | $23,265,000 | – | 2,326,500 | +100.0% | 0.30% | – |
| CASC | New | CASCADIAN THERAPEUTICS INC | $17,958,000 | – | 4,166,666 | +100.0% | 0.23% | – |
| BATRA | LIBERTY MEDIA CORP DELAWARE | $16,392,000 | +17.4% | 800,000 | 0.0% | 0.21% | +8.1% | |
| LEXEA | New | LIBERTY EXPEDIA HOLDINGS | $15,694,000 | – | 395,613 | +100.0% | 0.20% | – |
| RUN | SUNRUN INC | $15,123,000 | -15.7% | 2,848,082 | 0.0% | 0.20% | -22.7% | |
| CWSA | Sell | CITIGROUP INC*w exp 01/04/201 | $9,561,000 | +78.6% | 62,903,207 | -38.7% | 0.12% | +64.5% |
| TMQ | TRILOGY METALS INC NEW | $5,339,000 | -8.0% | 10,600,758 | 0.0% | 0.07% | -14.6% | |
| OREXQ | OREXIGEN THERAPEUTICS INC | $3,875,000 | -47.6% | 2,226,839 | 0.0% | 0.05% | -51.4% | |
| CPAAW | CONYERS PK ACQUISITION*w exp 07/20/202 | $2,475,000 | +73.9% | 1,237,500 | 0.0% | 0.03% | +60.0% | |
| SCACW | New | SABAN CAP ACQUISITION CORP*w exp 09/21/202 | $1,105,000 | – | 1,163,250 | +100.0% | 0.01% | – |
| SRAQW | Exit | SILVER RUN ACQUISITION CORP*w exp 02/23/202 | $0 | – | -950,000 | -100.0% | -0.08% | – |
| TBRA | Exit | TOBIRA THERAPEUTICS INC | $0 | – | -160,829 | -100.0% | -0.09% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -3,011,584 | -100.0% | -0.21% | – |
| SCACU | Exit | SABAN CAP ACQUISITION CORPunit 99/99/9999 | $0 | – | -2,326,500 | -100.0% | -0.33% | – |
| CASC | Exit | CASCADIAN THERAPEUTICS INC | $0 | – | -25,000,000 | -100.0% | -0.58% | – |
| ODP | Exit | OFFICE DEPOT INC | $0 | – | -13,000,000 | -100.0% | -0.66% | – |
| SRAQ | Exit | SILVER RUN ACQUISITION CORPcl a | $0 | – | -3,750,000 | -100.0% | -0.84% | – |
| KLXI | Exit | KLX INC | $0 | – | -2,000,000 | -100.0% | -1.00% | – |
| R114PS | Exit | CHIPMOS TECH BERMUDA LTD | $0 | – | -3,751,853 | -100.0% | -1.06% | – |
| LVNTA | Exit | LIBERTY INTERACTIVE CORP | $0 | – | -2,469,533 | -100.0% | -1.40% | – |
| VMW | Exit | VMWARE INC | $0 | – | -1,603,889 | -100.0% | -1.67% | – |
| OLN | Exit | OLIN CORP | $0 | – | -6,181,302 | -100.0% | -1.80% | – |
| PYPL | Exit | PAYPAL HLDGS INC | $0 | – | -5,000,000 | -100.0% | -2.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
About Baupost Group
Baupost Group is a Boston-based hedge fund founded by Seth Klarman in 1982. Klarman is a well-known value investor and author of the book "Margin of Safety". The firm has a reputation for being one of the most successful and secretive hedge funds in the world, with a focus on distressed debt, value investing, and event-driven strategies.
Baupost Group has a team of experienced investment professionals, including CEO and President James Mooney, COO Michael Apfel, and Chief Investment Officer Seth Klarman. The firm manages over $30 billion in assets and has a long-term investment horizon, often holding positions for several years.
The firm's investment philosophy is centered around the concept of margin of safety, which involves buying assets at a significant discount to their intrinsic value to minimize downside risk. Baupost Group is known for its disciplined approach to investing, conducting extensive research and analysis before making any investment decisions.
Baupost Group has a history of successful investments, including distressed debt investments in companies such as Enron and WorldCom. The firm also made a significant profit from its investment in the distressed debt of Lehman Brothers following the financial crisis.
Overall, Baupost Group is a highly respected hedge fund with a strong track record of successful investments. However, as with any investment, it is important for investors to conduct their own research and due diligence before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIASAT INC | 42 | Q3 2023 | 20.0% |
| THERAVANCE BIOPHARMA INC | 38 | Q3 2023 | 4.2% |
| VERITIV CORP | 37 | Q3 2023 | 10.8% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 4.2% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.4% |
| QORVO INC | 27 | Q3 2023 | 9.7% |
| CHENIERE ENERGY INC | 25 | Q1 2020 | 19.1% |
| THERAVANCE BIOPHARMA INC | 23 | Q2 2022 | 0.5% |
| NOVAGOLD RES INC | 22 | Q3 2018 | 1.9% |
| LIBERTY GLOBAL PLC | 21 | Q3 2023 | 16.6% |
View Baupost Group's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Garrett Motion Inc. | August 10, 2023 | 5,987,289 | 2.3% |
| Theravance Biopharma, Inc. | July 10, 2023 | 7,419,226 | 12.8% |
| Outbrain Inc. | May 09, 2023 | 4,720,000 | 8.4% |
| Archaea Energy Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Liberty Media Corp | February 14, 2023 | 7,677,656 | 7.8% |
| Altimeter Growth Corp. 2Sold out | February 13, 2023 | 0 | 0.0% |
| Avanti Acquisition Corp.Sold out | February 13, 2023 | 0 | 0.0% |
| Liberty Media Acquisition CorpSold out | February 13, 2023 | 0 | 0.0% |
| Liberty Media Corp | February 13, 2023 | 13,651,048 | 6.2% |
| VERINT SYSTEMS INCSold out | February 13, 2023 | 0 | 0.0% |
View Baupost Group's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| SC 13G | 2024-02-13 |
| SC 13G/A | 2024-01-09 |
| 4 | 2023-12-06 |
| SC 13D/A | 2023-12-04 |
| 13F-HR | 2023-11-13 |
View Baupost Group's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.